[Elsevier] Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial |
|
This post will be closed automatically in 2026-08-03 23:31
Reward10points
|
40
Street women empowered and engaged to stop TB: A ＆mixed method＊ study
40
Effectiveness of e-learning modules in community-based tuberculosis awareness programs
40
Community empowerment through technology-enabled health education for tuberculosis control
10
Factors Associated With Surgical Outcomes in Medial Orbital Wall Fracture Reconstruction With Absorbable Plates
10
Mapping protein每DNA interactions across biological scales: principles, scalability and applications
